US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Ryder

244.93

-3.7900-1.52%

Post-market: 244.930.00000.00%19:30 EDT

Volume:261.67K

Turnover:64.27M

Market Cap:9.39B

PE:19.87

High:252.20

Open:250.26

Low:243.54

Close:248.72

52wk High:284.25

52wk Low:157.67

Shares:38.35M

Float Shares:36.85M

Volume Ratio:0.83

T/O Rate:0.71%

Dividend:3.64

Dividend Rate:1.49%

EPS(TTM):12.33

EPS(LYR):11.94

ROE:16.70%

ROA:3.89%

PB:3.26

PE(LYR):20.52

Loading ...

Overview Company News Filings

Press Release: Chemtrade Logistics Income Fund Announces Results for the Second Quarter of 2026 and Reiterates 2026 Adjusted Ebitda Guidance of $485 to $525 Million

Press Release: Global Crossing Airlines Reports Second Quarter 2026 Financial Results

Press Release: AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Press Release: Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update

Press Release: MaxCyte Reports Second Quarter 2026 Financial Results

Press Release: SERA Prognostics Reports Second Quarter 2026 Financial Results

Press Release: Atea Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

Press Release: SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Press Release: QT Imaging Delivers Strong Second Quarter Growth While Building the Foundation for Commercial Scale

Press Release: BioStem Technologies Reports Second Quarter 2026 Financial Results

Press Release: Alto Neuroscience Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Press Release: Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Press Release: IceCure Reports Its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-over-Year

Press Release: Masco Corporation Declares Quarterly Dividend

Press Release: Madrigal Appoints John C. Reed, M.D., Ph.D., to Its Board of Directors

Press Release: Keurig Dr Pepper Announces Appointment of New Director to Its Board

Press Release: Adagene Reports Six Months 2026 Financial Results and Provides Corporate Updates

Press Release: Kamada Reports Record-High First Half and Second Quarter 2026 Financial Results, Representing Double-Digit Profitable Growth and the Strongest in Kamada's History; Affirms 2026 Annual Guidance

Press Release: Kamada Announces Planned Transition of Chief Financial Officer

Press Release: Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/R/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"R","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"R\",,,,,undefined,":{"symbol":"R","market":"US","secType":"STK","nameCN":"Ryder","latestPrice":244.93,"timestamp":1787601600000,"preClose":248.72,"halted":0,"volume":261670,"hourTrading":{"tag":"盘后","latestPrice":244.93,"preClose":244.93,"latestTime":"19:30 EDT","volume":38411,"amount":9408012.93,"timestamp":1787614205810,"change":0,"changeRate":0,"amplitude":0.000367},"delay":0,"changeRate":-0.015238018655516211,"floatShares":36853364,"shares":38346868,"eps":12.325055,"marketStatus":"Closed","change":-3.79,"latestTime":"08-24 16:00:00 EDT","open":250.26,"high":252.2,"low":243.535,"amount":64271348.7662,"amplitude":0.034838,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":12.325055,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":-292968000000,"exchange":"NYSE","adjPreClose":248.72,"dividendRate":0.014861,"preHourTrading":{"tag":"盘前","latestPrice":246.48,"preClose":248.72,"latestTime":"09:29 EDT","volume":120,"amount":29610.6696,"timestamp":1787578199999,"change":-2.24,"changeRate":-0.009006,"amplitude":0.013067},"postHourTrading":{"tag":"盘后","latestPrice":244.93,"preClose":244.93,"latestTime":"19:30 EDT","volume":38411,"amount":9408012.93,"timestamp":1787614205810,"change":0,"changeRate":0,"amplitude":0.000367},"volumeRatio":0.827647,"impliedVol":0.322,"impliedVolPercentile":0.2669},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"R\",,,,,undefined,":{"symbol":"R","floatShares":36853364,"roa":"3.89%","roe":"16.70%","lyrEps":11.937799,"volumeRatio":0.827647,"shares":38346868,"dividePrice":3.64,"high":252.2,"amplitude":0.034838,"preClose":248.72,"low":243.535,"week52Low":157.67,"pbRate":"3.26","psRate":"0.73","week52High":284.25,"institutionHeld":0.6518,"latestPrice":244.93,"eps":12.325055,"divideRate":0.014861,"volume":261670,"delay":0,"ttmEps":12.325055,"open":250.26,"prevYearClose":191.39,"prevWeekClose":249.73,"prevMonthClose":256.42,"prevQuarterClose":263.77,"fiveDayClose":264.7,"twentyDayClose":268.68,"sixtyDayClose":248.81,"dividendPayoutRate":0.28296082308697096,"dividendFrequency":"Q","dividendGrowthYears":10,"dividendGrowthRate":0.13157894736842102,"fiveYearAvgDividendRate":0.02341379230026732},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/R\",params:#limit:5,,,undefined,":[{"date":"2026-10-22","symbol":"R","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1792656000000,"name":null,"time":"Pre-MKt","dateTimestamp":1792641600000,"actualEps":null},{"date":"2026-08-24","symbol":"R","amount":1.01,"announcedDate":"2026-07-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-24","defaultRemindTime":1787578200000,"name":"瑞德系统","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-08-24","currency":"USD","dateTimestamp":1787544000000,"payDate":"2026-09-18"},{"market":"US","date":"2026-07-23","symbol":"R","fiscalQuarterEnding":"2026/06","expectedEps":3.7,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1784779200000,"reportTimeType":"pre","actualEps":3.73},{"date":"2026-05-18","symbol":"R","amount":0.91,"announcedDate":"2026-05-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-18","defaultRemindTime":1779111000000,"name":"瑞德系统","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-19","payableDate":"2026-05-18","currency":"USD","dateTimestamp":1779076800000,"payDate":"2026-06-19"},{"market":"US","date":"2026-04-23","symbol":"R","fiscalQuarterEnding":"2026/03","expectedEps":2.29,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1776916800000,"reportTimeType":"pre","actualEps":2.54}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"R\",market:\"US\",,,undefined,":[{"executeDate":"2016-11-17","recordDate":"2016-11-21","paymentDate":"2016-12-16","value":0.44,"currency":"USD"},{"executeDate":"2017-02-16","recordDate":"2017-02-21","paymentDate":"2017-03-17","value":0.44,"currency":"USD"},{"executeDate":"2017-05-18","recordDate":"2017-05-22","paymentDate":"2017-06-16","value":0.44,"currency":"USD"},{"executeDate":"2017-08-17","recordDate":"2017-08-21","paymentDate":"2017-09-15","value":0.46,"currency":"USD"},{"executeDate":"2017-11-17","recordDate":"2017-11-20","paymentDate":"2017-12-15","value":0.46,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"R\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.5,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":12,"updateTime":1784952000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/R\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"R","date":"2026-08-21","current":19.870905,"percent":0.947111,"low":4.335476,"twenty":5.686328,"median":12.170685,"eighty":15.174788,"high":21.956761,"avg":11.36875,"sd":4.610198,"marketCap":9504271233},"quantilePoints":[{"date":"2021-08-27","current":16.714761,"twenty":-7.755803,"median":9.861819,"eighty":16.769077,"marketCap":4369104918},{"date":"2021-09-03","current":16.395895,"twenty":-7.751218,"median":9.87728,"eighty":16.767739,"marketCap":4285755840},{"date":"2021-09-10","current":16.046171,"twenty":-7.751218,"median":9.87728,"eighty":16.767739,"marketCap":4194340722},{"date":"2021-09-17","current":16.161374,"twenty":-7.751218,"median":9.87728,"eighty":16.767739,"marketCap":4224453937},{"date":"2021-09-24","current":16.916367,"twenty":-7.751218,"median":9.87728,"eighty":16.7724,"marketCap":4421803045},{"date":"2021-10-01","current":17.126202,"twenty":-7.751218,"median":9.87728,"eighty":16.824146,"marketCap":4476652116},{"date":"2021-10-08","current":17.115916,"twenty":-7.751218,"median":9.87728,"eighty":16.86858,"marketCap":4473963436},{"date":"2021-10-15","current":17.229062,"twenty":-7.751218,"median":9.87728,"eighty":16.897726,"marketCap":4503538916},{"date":"2021-10-22","current":18.296749,"twenty":-7.751218,"median":9.87728,"eighty":16.957122,"marketCap":4782623895},{"date":"2021-10-29","current":12.544258,"twenty":-7.746632,"median":9.89274,"eighty":16.972991,"marketCap":4561242691},{"date":"2021-11-05","current":12.858787,"twenty":-7.746632,"median":9.89274,"eighty":16.972991,"marketCap":4675609342},{"date":"2021-11-12","current":12.99464,"twenty":-7.746632,"median":9.89274,"eighty":16.946201,"marketCap":4725007144},{"date":"2021-11-19","current":12.432031,"twenty":-7.746632,"median":9.89274,"eighty":16.881013,"marketCap":4520435811},{"date":"2021-11-26","current":12.601848,"twenty":-7.746632,"median":9.89274,"eighty":16.848905,"marketCap":4582183064},{"date":"2021-12-03","current":11.712896,"twenty":-7.746632,"median":9.89274,"eighty":16.823699,"marketCap":4258949621},{"date":"2021-12-10","current":11.980172,"twenty":-7.746632,"median":9.89274,"eighty":16.771738,"marketCap":4356134427},{"date":"2021-12-17","current":11.548987,"twenty":-7.746632,"median":9.89274,"eighty":16.734025,"marketCap":4199350099},{"date":"2021-12-23","current":11.717326,"twenty":-7.746632,"median":9.89274,"eighty":16.724457,"marketCap":4260560419},{"date":"2021-12-31","current":12.172139,"twenty":-7.746632,"median":9.89274,"eighty":16.688297,"marketCap":4425935669},{"date":"2022-01-07","current":11.528313,"twenty":-7.742047,"median":9.894559,"eighty":16.645088,"marketCap":4191833042},{"date":"2022-01-14","current":11.66269,"twenty":-7.742047,"median":9.894559,"eighty":16.569237,"marketCap":4240693911},{"date":"2022-01-21","current":11.074978,"twenty":-7.742047,"median":9.894559,"eighty":16.518713,"marketCap":4026994725},{"date":"2022-01-28","current":10.665942,"twenty":-7.742047,"median":9.894559,"eighty":16.390958,"marketCap":3878264386},{"date":"2022-02-04","current":10.595062,"twenty":-7.742047,"median":9.894559,"eighty":16.292436,"marketCap":3852491620},{"date":"2022-02-11","current":10.866768,"twenty":-7.742047,"median":9.894559,"eighty":16.266226,"marketCap":3951287224},{"date":"2022-02-18","current":8.156002,"twenty":-7.742047,"median":9.819077,"eighty":16.167134,"marketCap":4232965038},{"date":"2022-02-25","current":8.041976,"twenty":-7.742047,"median":9.683571,"eighty":16.061394,"marketCap":4173785303},{"date":"2022-03-04","current":8.192283,"twenty":-7.742047,"median":9.408015,"eighty":15.879949,"marketCap":4251794953},{"date":"2022-03-11","current":8.208869,"twenty":-7.742047,"median":8.965509,"eighty":15.706321,"marketCap":4260402915},{"date":"2022-03-18","current":8.2995,"twenty":-7.742047,"median":8.822833,"eighty":15.524465,"marketCap":4307440377},{"date":"2022-03-25","current":7.957709,"twenty":-7.742047,"median":8.777473,"eighty":15.400744,"marketCap":4130051128},{"date":"2022-04-01","current":7.287918,"twenty":-7.742047,"median":8.581191,"eighty":15.306166,"marketCap":3782429545},{"date":"2022-04-08","current":6.216252,"twenty":-7.742047,"median":8.486348,"eighty":15.123407,"marketCap":3226235013},{"date":"2022-04-14","current":6.305886,"twenty":-7.742047,"median":8.400577,"eighty":15.064281,"marketCap":3272754960},{"date":"2022-04-22","current":6.644722,"twenty":-7.742047,"median":8.337941,"eighty":15.019858,"marketCap":3448610584},{"date":"2022-04-29","current":5.552093,"twenty":-7.742047,"median":8.266103,"eighty":15.01151,"marketCap":3574453932},{"date":"2022-05-06","current":5.903169,"twenty":-7.742047,"median":8.228212,"eighty":15.01151,"marketCap":3800478057},{"date":"2022-05-13","current":6.644243,"twenty":-7.742047,"median":8.178807,"eighty":15.01151,"marketCap":4277583282},{"date":"2022-05-20","current":6.306669,"twenty":-7.742047,"median":8.111521,"eighty":15.01151,"marketCap":4060252392},{"date":"2022-05-27","current":6.362269,"twenty":-7.742047,"median":8.052823,"eighty":15.01151,"marketCap":4096048068},{"date":"2022-06-03","current":6.481413,"twenty":-7.742047,"median":8.032181,"eighty":15.01151,"marketCap":4172753088},{"date":"2022-06-10","current":6.150194,"twenty":-7.742047,"median":8.016693,"eighty":15.01151,"marketCap":3959513132},{"date":"2022-06-17","current":5.747488,"twenty":-7.742047,"median":7.956055,"eighty":15.01151,"marketCap":3700250164},{"date":"2022-06-24","current":5.650585,"twenty":-7.746632,"median":7.945333,"eighty":15.013418,"marketCap":3637863415},{"date":"2022-07-01","current":5.726042,"twenty":-7.746632,"median":7.897499,"eighty":15.013418,"marketCap":3686443261},{"date":"2022-07-08","current":5.746694,"twenty":-7.746632,"median":7.835691,"eighty":15.013418,"marketCap":3699738798},{"date":"2022-07-15","current":5.766551,"twenty":-7.746632,"median":7.772142,"eighty":15.013418,"marketCap":3712522968},{"date":"2022-07-22","current":5.926204,"twenty":-7.746632,"median":7.442255,"eighty":15.013418,"marketCap":3815307694},{"date":"2022-07-29","current":5.461894,"twenty":-7.746632,"median":6.699881,"eighty":15.013418,"marketCap":4009565771},{"date":"2022-08-05","current":5.457013,"twenty":-7.746632,"median":6.644722,"eighty":15.013418,"marketCap":4005982145},{"date":"2022-08-12","current":5.788269,"twenty":-7.746632,"median":6.481413,"eighty":15.013418,"marketCap":4249156780},{"date":"2022-08-19","current":5.654372,"twenty":-7.746632,"median":6.388625,"eighty":15.013418,"marketCap":4150863032},{"date":"2022-08-26","current":5.604858,"twenty":-7.746632,"median":6.320172,"eighty":15.013418,"marketCap":4114514824},{"date":"2022-09-02","current":5.186429,"twenty":-7.746632,"median":6.234388,"eighty":15.013418,"marketCap":3807346864},{"date":"2022-09-09","current":5.427723,"twenty":-7.746632,"median":6.204433,"eighty":15.013418,"marketCap":3984480387},{"date":"2022-09-16","current":4.997438,"twenty":-7.746632,"median":6.039787,"eighty":15.013418,"marketCap":3668609335},{"date":"2022-09-23","current":4.66409,"twenty":-7.746632,"median":5.934147,"eighty":15.013418,"marketCap":3423898860},{"date":"2022-09-30","current":5.264535,"twenty":-7.746632,"median":5.891255,"eighty":14.984817,"marketCap":3864684883},{"date":"2022-10-07","current":5.515593,"twenty":-7.746632,"median":5.79038,"eighty":14.962577,"marketCap":4048985659},{"date":"2022-10-14","current":5.330787,"twenty":-7.746632,"median":5.747488,"eighty":14.951585,"marketCap":3913319810},{"date":"2022-10-21","current":5.177363,"twenty":-7.746632,"median":5.716511,"eighty":14.921021,"marketCap":3800691558},{"date":"2022-10-28","current":4.875682,"twenty":-7.746632,"median":5.696654,"eighty":14.896597,"marketCap":4105514216},{"date":"2022-11-04","current":4.97415,"twenty":-7.746632,"median":5.677591,"eighty":14.776301,"marketCap":4188428518},{"date":"2022-11-11","current":5.292233,"twenty":-7.746632,"median":5.663293,"eighty":14.711779,"marketCap":4456266838},{"date":"2022-11-18","current":5.380557,"twenty":-7.746632,"median":5.641848,"eighty":14.711779,"marketCap":4530638454},{"date":"2022-11-25","current":5.732059,"twenty":-7.746632,"median":5.632098,"eighty":14.711779,"marketCap":4826617386},{"date":"2022-12-02","current":5.390702,"twenty":-7.746632,"median":5.616713,"eighty":13.024764,"marketCap":4539181140},{"date":"2022-12-09","current":5.00757,"twenty":-7.746632,"median":5.60073,"eighty":12.852585,"marketCap":4216569129},{"date":"2022-12-16","current":5.043377,"twenty":-7.746632,"median":5.579284,"eighty":12.794995,"marketCap":4246719784},{"date":"2022-12-23","current":5.054119,"twenty":-7.746632,"median":5.556738,"eighty":12.683064,"marketCap":4255764981},{"date":"2022-12-30","current":4.987279,"twenty":-7.746632,"median":5.542093,"eighty":12.55727,"marketCap":4199483758},{"date":"2023-01-06","current":4.977134,"twenty":-7.746632,"median":5.530238,"eighty":12.411068,"marketCap":4190941072},{"date":"2023-01-13","current":5.452767,"twenty":-7.746632,"median":5.515593,"eighty":12.297336,"marketCap":4591442276},{"date":"2023-01-20","current":5.542284,"twenty":-7.746632,"median":5.512803,"eighty":12.262396,"marketCap":4666818914},{"date":"2023-01-27","current":5.635978,"twenty":-7.746632,"median":5.512803,"eighty":12.179012,"marketCap":4745713128},{"date":"2023-02-03","current":5.849625,"twenty":-7.746632,"median":5.504687,"eighty":12.076451,"marketCap":4925612037},{"date":"2023-02-10","current":5.754737,"twenty":-7.746632,"median":5.504687,"eighty":12.026911,"marketCap":4845712801},{"date":"2023-02-17","current":5.263255,"twenty":-7.746632,"median":5.498719,"eighty":11.969767,"marketCap":4563242372},{"date":"2023-02-24","current":5.148999,"twenty":-7.746632,"median":5.492154,"eighty":11.969767,"marketCap":4464182332},{"date":"2023-03-03","current":5.301697,"twenty":-7.746632,"median":5.485925,"eighty":11.969767,"marketCap":4596570983},{"date":"2023-03-10","current":4.857486,"twenty":-7.746632,"median":5.474851,"eighty":11.969767,"marketCap":4211440363},{"date":"2023-03-17","current":4.455455,"twenty":-7.746632,"median":5.452767,"eighty":11.969767,"marketCap":3862879398},{"date":"2023-03-24","current":4.499409,"twenty":-7.746632,"median":5.427723,"eighty":11.969767,"marketCap":3900987688},{"date":"2023-03-31","current":4.783503,"twenty":-7.742047,"median":5.424379,"eighty":11.966298,"marketCap":4147297371},{"date":"2023-04-06","current":4.522458,"twenty":-7.742047,"median":5.424379,"eighty":11.966298,"marketCap":3920971304},{"date":"2023-04-14","current":4.579277,"twenty":-7.746632,"median":5.427723,"eighty":11.969767,"marketCap":3970233240},{"date":"2023-04-21","current":4.639312,"twenty":-7.746632,"median":5.394248,"eighty":11.969767,"marketCap":4022283588},{"date":"2023-04-28","current":4.360113,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3618893391},{"date":"2023-05-05","current":4.456979,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3699292590},{"date":"2023-05-12","current":4.543916,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3771449940},{"date":"2023-05-19","current":4.544476,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3771914863},{"date":"2023-05-26","current":4.48342,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3721238329},{"date":"2023-06-02","current":4.478378,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3717054028},{"date":"2023-06-09","current":4.659306,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3867223940},{"date":"2023-06-16","current":4.628498,"twenty":-7.746632,"median":5.392854,"eighty":11.969767,"marketCap":3841653212},{"date":"2023-06-23","current":4.605532,"twenty":-7.751218,"median":5.393551,"eighty":11.973235,"marketCap":3822591397},{"date":"2023-06-30","current":4.710279,"twenty":-7.755803,"median":5.394248,"eighty":11.976704,"marketCap":3909531872},{"date":"2023-07-07","current":4.670509,"twenty":-7.755803,"median":5.394248,"eighty":11.976704,"marketCap":3876522387},{"date":"2023-07-14","current":4.972428,"twenty":-7.755803,"median":5.394248,"eighty":11.976704,"marketCap":4127115523},{"date":"2023-07-21","current":5.1696,"twenty":-7.755803,"median":5.394248,"eighty":11.976704,"marketCap":4290768183},{"date":"2023-07-28","current":7.905694,"twenty":-7.755803,"median":5.397863,"eighty":11.976704,"marketCap":4529962569},{"date":"2023-08-04","current":7.943832,"twenty":-7.755803,"median":5.452767,"eighty":11.976704,"marketCap":4551815654},{"date":"2023-08-11","current":8.064602,"twenty":-7.755803,"median":5.493974,"eighty":11.976704,"marketCap":4621017093},{"date":"2023-08-18","current":7.684017,"twenty":-7.755803,"median":5.519009,"eighty":11.976704,"marketCap":4402941508},{"date":"2023-08-25","current":7.629988,"twenty":-7.755803,"median":5.540699,"eighty":11.976704,"marketCap":4371982969},{"date":"2023-09-01","current":8.001039,"twenty":-7.755803,"median":5.556738,"eighty":11.976704,"marketCap":4584595283},{"date":"2023-09-08","current":7.796047,"twenty":-7.755803,"median":5.572744,"eighty":11.976704,"marketCap":4467134947},{"date":"2023-09-15","current":8.072548,"twenty":-7.755803,"median":5.598162,"eighty":11.976704,"marketCap":4625569819},{"date":"2023-09-22","current":8.255292,"twenty":-7.755803,"median":5.622292,"eighty":11.976704,"marketCap":4730282521},{"date":"2023-09-29","current":8.464257,"twenty":-7.755803,"median":5.641349,"eighty":11.976704,"marketCap":4850019220},{"date":"2023-10-06","current":7.874707,"twenty":-7.755803,"median":5.654372,"eighty":11.976704,"marketCap":4512206936},{"date":"2023-10-13","current":8.166304,"twenty":-7.755803,"median":5.677385,"eighty":11.976704,"marketCap":4679291988},{"date":"2023-10-20","current":7.969257,"twenty":-7.755803,"median":5.687122,"eighty":11.976704,"marketCap":4566384378},{"date":"2023-10-27","current":8.466638,"twenty":-7.81017,"median":5.70583,"eighty":11.984307,"marketCap":4131719492},{"date":"2023-11-03","current":8.900778,"twenty":-7.81017,"median":5.736104,"eighty":11.984307,"marketCap":4343579814},{"date":"2023-11-10","current":9.098775,"twenty":-7.81017,"median":5.748824,"eighty":11.984307,"marketCap":4440202303},{"date":"2023-11-17","current":9.541998,"twenty":-7.81017,"median":5.774024,"eighty":11.984307,"marketCap":4656494849},{"date":"2023-11-24","current":9.76815,"twenty":-7.81017,"median":5.792649,"eighty":11.984307,"marketCap":4766857234},{"date":"2023-12-01","current":9.730912,"twenty":-7.81017,"median":5.832915,"eighty":11.984307,"marketCap":4748685115},{"date":"2023-12-08","current":9.643721,"twenty":-7.785279,"median":5.902141,"eighty":11.982239,"marketCap":4706135761},{"date":"2023-12-15","current":10.11964,"twenty":-7.785279,"median":5.934147,"eighty":11.982239,"marketCap":4938384315},{"date":"2023-12-22","current":10.650962,"twenty":-7.785279,"median":6.039787,"eighty":11.982239,"marketCap":5197669436},{"date":"2023-12-29","current":10.469313,"twenty":-7.81017,"median":6.186334,"eighty":11.984307,"marketCap":5109024950},{"date":"2024-01-05","current":10.161419,"twenty":-7.835061,"median":6.212148,"eighty":11.986374,"marketCap":4958772546},{"date":"2024-01-12","current":10.035173,"twenty":-7.835061,"median":6.306669,"eighty":11.986374,"marketCap":4897164629},{"date":"2024-01-19","current":10.137805,"twenty":-7.859952,"median":6.350752,"eighty":11.988442,"marketCap":4947248763},{"date":"2024-01-26","current":10.437525,"twenty":-7.835061,"median":6.413898,"eighty":11.986374,"marketCap":5093512165},{"date":"2024-02-02","current":10.526533,"twenty":-7.835061,"median":6.548928,"eighty":11.986374,"marketCap":5136947963},{"date":"2024-02-09","current":10.603733,"twenty":-7.835061,"median":6.662452,"eighty":11.986374,"marketCap":5174621870},{"date":"2024-02-16","current":11.958272,"twenty":-7.835061,"median":6.699881,"eighty":11.992994,"marketCap":4855058498},{"date":"2024-02-23","current":12.181128,"twenty":-7.835061,"median":6.699881,"eighty":12.003352,"marketCap":4945538144},{"date":"2024-03-01","current":12.341207,"twenty":-7.81017,"median":6.732825,"eighty":12.070758,"marketCap":5010530121},{"date":"2024-03-08","current":12.549959,"twenty":-7.81017,"median":6.732825,"eighty":12.1283,"marketCap":5095283172},{"date":"2024-03-15","current":12.315273,"twenty":-7.81017,"median":6.732825,"eighty":12.192966,"marketCap":5000001022},{"date":"2024-03-22","current":12.709973,"twenty":-7.81017,"median":6.732825,"eighty":12.252055,"marketCap":5160248952},{"date":"2024-03-28","current":12.9324,"twenty":-7.81017,"median":6.732825,"eighty":12.27243,"marketCap":5250554416},{"date":"2024-04-05","current":12.824457,"twenty":-7.835061,"median":6.699881,"eighty":12.310529,"marketCap":5206729706},{"date":"2024-04-12","current":12.753586,"twenty":-7.835061,"median":6.699881,"eighty":12.337386,"marketCap":5177955906},{"date":"2024-04-19","current":11.685063,"twenty":-7.835061,"median":6.699881,"eighty":12.340342,"marketCap":4744135543},{"date":"2024-04-26","current":15.244202,"twenty":-7.81017,"median":6.732825,"eighty":12.359817,"marketCap":5365959126},{"date":"2024-05-03","current":15.528093,"twenty":-7.81017,"median":6.732825,"eighty":12.422817,"marketCap":5465888775},{"date":"2024-05-10","current":15.863035,"twenty":-7.81017,"median":6.732825,"eighty":12.516984,"marketCap":5583788228},{"date":"2024-05-17","current":15.561712,"twenty":-7.81017,"median":6.732825,"eighty":12.565399,"marketCap":5477722549},{"date":"2024-05-24","current":14.992685,"twenty":-7.81017,"median":6.732825,"eighty":12.683064,"marketCap":5277424965},{"date":"2024-05-31","current":15.007626,"twenty":-7.81017,"median":6.732825,"eighty":12.75491,"marketCap":5282684420},{"date":"2024-06-07","current":14.981478,"twenty":-7.81017,"median":6.732825,"eighty":12.826376,"marketCap":5273480373},{"date":"2024-06-14","current":14.965292,"twenty":-7.835061,"median":6.699881,"eighty":12.854653,"marketCap":5267782630},{"date":"2024-06-21","current":15.053696,"twenty":-7.859952,"median":6.696926,"eighty":12.903973,"marketCap":5298901073},{"date":"2024-06-28","current":15.257899,"twenty":-7.926764,"median":6.670331,"eighty":12.934444,"marketCap":5370780294},{"date":"2024-07-05","current":15.332607,"twenty":-7.926764,"median":6.670331,"eighty":13.078605,"marketCap":5397077570},{"date":"2024-07-12","current":15.560467,"twenty":-7.926764,"median":6.670331,"eighty":14.67393,"marketCap":5477284261},{"date":"2024-07-15","current":16.031128,"twenty":-7.926764,"median":6.670331,"eighty":14.798941,"marketCap":5642957098},{"date":"2024-08-02","current":12.046137,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5986929872},{"date":"2024-08-09","current":11.643786,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5786961567},{"date":"2024-08-16","current":11.960789,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5944512353},{"date":"2024-08-23","current":12.044395,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5986064208},{"date":"2024-08-30","current":12.267342,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":6096869157},{"date":"2024-09-06","current":11.844961,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5886945719},{"date":"2024-09-13","current":11.837994,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5883483065},{"date":"2024-09-20","current":12.877836,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":6400284270},{"date":"2024-09-27","current":12.605247,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":6264807907},{"date":"2024-10-04","current":12.39275,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":6159196940},{"date":"2024-10-11","current":12.762878,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":6343150468},{"date":"2024-10-18","current":12.754684,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":6339078000},{"date":"2024-10-25","current":12.285395,"twenty":-8.0879,"median":6.543636,"eighty":14.889338,"marketCap":5872418977},{"date":"2024-10-31","current":13.170128,"twenty":-8.0879,"median":6.543636,"eighty":14.807159,"marketCap":6295321107},{"date":"2024-11-08","current":14.050437,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":6716108726},{"date":"2024-11-15","current":14.657363,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":7006219587},{"date":"2024-11-22","current":14.262772,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":6817605237},{"date":"2024-11-29","current":14.937823,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":7140279562},{"date":"2024-12-06","current":14.566236,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":6962660668},{"date":"2024-12-13","current":14.75026,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":7050624311},{"date":"2024-12-20","current":13.771746,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":6582894555},{"date":"2024-12-27","current":14.153066,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":6765165373},{"date":"2025-01-03","current":13.844294,"twenty":-8.107223,"median":6.538343,"eighty":13.266011,"marketCap":6617572530},{"date":"2025-01-10","current":14.016817,"twenty":-8.126546,"median":6.509878,"eighty":13.206393,"marketCap":6700038445},{"date":"2025-01-17","current":14.647631,"twenty":-8.126546,"median":6.509878,"eighty":13.206393,"marketCap":7001567664},{"date":"2025-01-24","current":14.644977,"twenty":-8.126546,"median":6.509878,"eighty":13.206393,"marketCap":7000298957},{"date":"2025-01-31","current":14.36894,"twenty":-8.126546,"median":6.509878,"eighty":13.206393,"marketCap":6868353493},{"date":"2025-02-07","current":13.879683,"twenty":-8.126546,"median":6.509878,"eighty":13.206393,"marketCap":6634488615},{"date":"2025-02-14","current":13.862207,"twenty":-8.03386,"median":6.543636,"eighty":13.316137,"marketCap":6778619352},{"date":"2025-02-21","current":14.292524,"twenty":-7.746632,"median":6.652028,"eighty":13.787317,"marketCap":6989043992},{"date":"2025-02-28","current":13.739137,"twenty":-7.30351,"median":6.732825,"eighty":13.829167,"marketCap":6718437905},{"date":"2025-03-07","current":13.320009,"twenty":-6.938007,"median":7.55689,"eighty":13.830759,"marketCap":6513484306},{"date":"2025-03-14","current":11.737306,"twenty":-6.885604,"median":7.691962,"eighty":13.830759,"marketCap":5739542480},{"date":"2025-03-21","current":11.989848,"twenty":-6.794229,"median":7.780156,"eighty":13.830759,"marketCap":5863035670},{"date":"2025-03-28","current":12.289466,"twenty":-6.704491,"median":7.818294,"eighty":13.830759,"marketCap":6009548949},{"date":"2025-04-04","current":11.830222,"twenty":-6.612788,"median":7.905144,"eighty":13.830759,"marketCap":5784978738},{"date":"2025-04-11","current":11.83449,"twenty":-6.460167,"median":7.944627,"eighty":13.830628,"marketCap":5787065822},{"date":"2025-04-17","current":11.790103,"twenty":-6.392044,"median":7.965682,"eighty":13.830628,"marketCap":5765360151},{"date":"2025-04-25","current":11.457658,"twenty":-6.145958,"median":8.001039,"eighty":13.830759,"marketCap":5751744390},{"date":"2025-05-02","current":11.438717,"twenty":-5.907983,"median":8.021733,"eighty":13.830759,"marketCap":5742236008},{"date":"2025-05-09","current":12.069535,"twenty":4.422322,"median":8.052268,"eighty":13.830759,"marketCap":6058906475},{"date":"2025-05-16","current":12.972115,"twenty":4.465495,"median":8.071753,"eighty":13.830759,"marketCap":6512001555},{"date":"2025-05-23","current":12.379179,"twenty":4.482002,"median":8.092411,"eighty":13.830759,"marketCap":6214347853},{"date":"2025-05-30","current":12.411296,"twenty":4.504369,"median":8.124987,"eighty":13.830759,"marketCap":6230470762},{"date":"2025-06-06","current":12.205416,"twenty":4.52924,"median":8.150819,"eighty":13.830759,"marketCap":6127118782},{"date":"2025-06-13","current":12.324003,"twenty":4.54414,"median":8.183784,"eighty":13.830759,"marketCap":6186649522},{"date":"2025-06-20","current":12.475531,"twenty":4.557695,"median":8.223114,"eighty":13.830891,"marketCap":6262716580},{"date":"2025-06-27","current":13.078349,"twenty":4.57381,"median":8.253849,"eighty":13.830891,"marketCap":6565331177},{"date":"2025-07-03","current":14.129163,"twenty":4.586262,"median":8.30557,"eighty":13.858624,"marketCap":7092839683},{"date":"2025-07-11","current":14.494806,"twenty":4.600504,"median":8.337941,"eighty":13.890852,"marketCap":7276392799},{"date":"2025-07-18","current":14.164574,"twenty":4.608827,"median":8.434859,"eighty":13.981782,"marketCap":7110616224},{"date":"2025-07-25","current":14.307417,"twenty":4.625011,"median":8.858999,"eighty":14.002789,"marketCap":7225245354},{"date":"2025-08-01","current":14.354265,"twenty":4.633104,"median":9.160989,"eighty":14.049906,"marketCap":7248903923},{"date":"2025-08-08","current":14.19918,"twenty":4.650193,"median":9.572878,"eighty":14.097858,"marketCap":7170585902},{"date":"2025-08-15","current":14.709669,"twenty":4.666003,"median":9.666427,"eighty":14.127845,"marketCap":7428382721},{"date":"2025-08-22","current":14.573161,"twenty":4.709831,"median":9.71638,"eighty":14.151964,"marketCap":7359446547},{"date":"2025-08-29","current":15.114344,"twenty":4.783503,"median":9.76815,"eighty":14.198571,"marketCap":7632743808},{"date":"2025-09-05","current":15.23712,"twenty":4.812786,"median":9.833544,"eighty":14.238885,"marketCap":7694745575},{"date":"2025-09-12","current":15.312239,"twenty":4.861125,"median":10.041985,"eighty":14.314092,"marketCap":7732680866},{"date":"2025-09-19","current":14.993992,"twenty":4.931659,"median":10.156878,"eighty":14.354103,"marketCap":7571965760},{"date":"2025-09-26","current":14.909987,"twenty":4.960305,"median":10.2309,"eighty":14.420027,"marketCap":7529543499},{"date":"2025-10-03","current":15.384936,"twenty":4.977731,"median":10.32899,"eighty":14.468748,"marketCap":7769392438},{"date":"2025-10-10","current":14.883332,"twenty":4.997531,"median":10.44025,"eighty":14.503112,"marketCap":7516082589},{"date":"2025-10-17","current":14.752479,"twenty":5.035793,"median":10.493382,"eighty":14.525335,"marketCap":7450001759},{"date":"2025-10-24","current":12.89259,"twenty":5.054716,"median":10.599398,"eighty":14.539205,"marketCap":6472080000},{"date":"2025-10-31","current":13.625069,"twenty":5.097183,"median":10.658452,"eighty":14.539205,"marketCap":6839784859},{"date":"2025-11-07","current":13.479489,"twenty":5.12209,"median":10.73345,"eighty":14.539205,"marketCap":6766703333},{"date":"2025-11-14","current":13.617026,"twenty":5.133219,"median":10.893348,"eighty":14.539205,"marketCap":6835747206},{"date":"2025-11-21","current":13.070093,"twenty":5.152815,"median":11.090483,"eighty":14.539205,"marketCap":6561186775},{"date":"2025-11-28","current":13.873602,"twenty":5.177781,"median":11.196803,"eighty":14.539205,"marketCap":6964548349},{"date":"2025-12-05","current":14.478446,"twenty":5.19145,"median":11.302112,"eighty":14.539205,"marketCap":7268179885},{"date":"2025-12-12","current":15.927014,"twenty":5.207168,"median":11.404144,"eighty":14.629582,"marketCap":7995361262},{"date":"2025-12-19","current":15.296433,"twenty":5.254517,"median":11.451225,"eighty":14.655417,"marketCap":7678809236},{"date":"2025-12-26","current":15.906907,"twenty":5.265027,"median":11.491086,"eighty":14.698585,"marketCap":7985267129},{"date":"2026-01-02","current":15.393755,"twenty":5.303504,"median":11.530528,"eighty":14.710447,"marketCap":7727664842},{"date":"2026-01-09","current":15.285172,"twenty":5.326043,"median":11.631919,"eighty":14.756356,"marketCap":7673156521},{"date":"2026-01-16","current":15.624593,"twenty":5.335095,"median":11.673876,"eighty":14.821626,"marketCap":7843545494},{"date":"2026-01-23","current":15.790281,"twenty":5.381631,"median":11.714373,"eighty":14.842245,"marketCap":7926721154},{"date":"2026-01-30","current":15.476599,"twenty":5.397735,"median":11.740952,"eighty":14.909825,"marketCap":7769252672},{"date":"2026-02-06","current":17.236437,"twenty":5.43372,"median":11.783021,"eighty":14.940109,"marketCap":8652691236},{"date":"2026-02-13","current":16.435376,"twenty":5.467946,"median":11.830222,"eighty":14.977245,"marketCap":8201252704},{"date":"2026-02-20","current":17.329797,"twenty":5.50631,"median":11.845396,"eighty":14.992461,"marketCap":8647568653},{"date":"2026-02-27","current":17.630044,"twenty":5.529122,"median":11.868324,"eighty":15.006515,"marketCap":8797392028},{"date":"2026-03-06","current":16.622636,"twenty":5.543836,"median":11.926274,"eighty":15.027061,"marketCap":8294695177},{"date":"2026-03-13","current":14.692322,"twenty":5.566305,"median":11.961621,"eighty":15.051953,"marketCap":7331468705},{"date":"2026-03-20","current":15.122092,"twenty":5.582426,"median":12.000539,"eighty":15.06114,"marketCap":7545923966},{"date":"2026-03-27","current":15.704285,"twenty":5.607776,"median":12.030258,"eighty":15.075828,"marketCap":7836438314},{"date":"2026-04-02","current":16.252694,"twenty":5.634545,"median":12.044612,"eighty":15.114182,"marketCap":8110094204},{"date":"2026-04-10","current":17.445365,"twenty":5.643595,"median":12.073512,"eighty":15.122356,"marketCap":8705236958},{"date":"2026-04-17","current":17.393509,"twenty":5.667538,"median":12.105673,"eighty":15.140077,"marketCap":8679361186},{"date":"2026-04-24","current":19.000109,"twenty":5.68188,"median":12.153841,"eighty":15.16364,"marketCap":9386054056},{"date":"2026-05-01","current":19.875748,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":9818619637},{"date":"2026-05-08","current":18.939802,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":9356261972},{"date":"2026-05-15","current":18.097058,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":8939946619},{"date":"2026-05-22","current":18.675857,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":9225873242},{"date":"2026-05-29","current":19.487272,"twenty":5.687122,"median":12.172139,"eighty":15.171984,"marketCap":9626712188},{"date":"2026-06-05","current":20.75217,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":10251572129},{"date":"2026-06-12","current":21.956761,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":10846639986},{"date":"2026-06-18","current":20.841457,"twenty":5.687122,"median":12.176633,"eighty":15.172298,"marketCap":10295679889},{"date":"2026-06-26","current":20.984003,"twenty":5.687122,"median":12.172139,"eighty":15.171984,"marketCap":10366097542},{"date":"2026-07-02","current":20.833625,"twenty":5.687122,"median":12.172139,"eighty":15.171984,"marketCap":10291810788},{"date":"2026-07-10","current":21.117934,"twenty":5.687122,"median":12.172139,"eighty":15.171984,"marketCap":10432259183},{"date":"2026-07-17","current":21.386578,"twenty":5.687122,"median":12.172139,"eighty":15.171984,"marketCap":10564969375},{"date":"2026-07-24","current":20.671045,"twenty":5.687122,"median":12.172139,"eighty":15.171984,"marketCap":10273509405},{"date":"2026-07-31","current":19.919539,"twenty":5.686328,"median":12.170685,"eighty":15.172062,"marketCap":9900010911},{"date":"2026-08-07","current":20.237425,"twenty":5.686328,"median":12.170685,"eighty":15.172062,"marketCap":10058000007},{"date":"2026-08-14","current":20.305322,"twenty":5.686328,"median":12.170685,"eighty":15.172062,"marketCap":10091745251},{"date":"2026-08-21","current":19.123282,"twenty":5.686328,"median":12.170685,"eighty":15.174788,"marketCap":9504271233}],"updateTime":1787599877599},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"R\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659185283","title":"Press Release: Chemtrade Logistics Income Fund Announces Results for the Second Quarter of 2026 and Reiterates 2026 Adjusted Ebitda Guidance of $485 to $525 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659185283","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659185283?lang=en_us&edition=fundamental","pubTime":"2026-08-13 06:00","pubTimestamp":1786572000,"startTime":"0","endTime":"0","summary":"year-over-year driven by the Polytec acquisition in the WS segment as. well as higher selling prices for merchant acid, sulphur products and. Regen acid in the ASP segment. This more than offset lower selling prices. of chlor-alkali products and lower volumes and selling prices for sodium. --  Adjusted EBITDA of $127.3 million, a decrease of $10.7 million or. at North Vancouver, Adjusted EBITDA was $3.7 million lower than 2025.Adjusted EBITDA from the Polytec acquisition and higher Adjusted EBITDA. from merchant and Regen acid were more than offset by lower selling. prices for chlor-alkali products and lower volumes and selling prices for. sodium chlorate. Adjusted EBITDA for water products was also lower as. higher selling prices did not fully offset higher input costs.year-over-year primarily due to an impairment of PPE in 2025 and lower. finance costs that were partially offset by lower Adjusted EBITDA,unfavourable unrealized foreign exchange losses, higher depreciation and. year. C","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACH","R","BK4090","BK4022","BK4175","BK4232","WS","BK4153","BK4006","CGIFF","SWC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659889471","title":"Press Release: Global Crossing Airlines Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659889471","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659889471?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:44","pubTimestamp":1786567440,"startTime":"0","endTime":"0","summary":"Improved Fleet Efficiency and Aircraft Utilization Drive EBITDA Growth Despite Fewer Net Available AircraftAdvances Fleet Modernization Initiative with Five New A320 Aircraft -- On Track to Reach 25-Aircraft Target by Year-EndMIAMI, Aug. 12, 2026  -- Global Crossing Airlines Group, Inc.  , The Nation's Fastest Growing Charter Airline , today announced its financial and operating results for the second quarter ended June 30, 2026. Except as otherwise disclosed, all figures are presented in United States dollars and prepared in accordance with U.S. GAAP.Financial and Operational Summary. ------------------------------------------  -------  -------  --------Management Commentary\"GlobalX delivered a solid second quarter, with results highlighting the resilience of our platform,\" said Chris Jamroz, Executive Chairman of GlobalX. \"Despite a period of highly intensified scheduled maintenance that meaningfully constrained aircraft availability, we maintained year-over-year revenue and delivere","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","JETMF","R","BK4008","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659990095","title":"Press Release: AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659990095","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659990095?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:15","pubTimestamp":1786565700,"startTime":"0","endTime":"0","summary":"-- AEON held a successful Biosimilar Biological Product Development.  Type 2a meeting with the U.S. Food and Drug Administration.  during the first quarter of 2026. During the meeting, the. strategy under the 351 biosimilar pathway and provided feedback. ABP-450. Collectively, the FDA's feedback provided AEON with. well-defined direction and a framework for the remaining. analytical components of its biosimilar development program. The. associated with characterizing the 900 kDa botulinum neurotoxin. complex due to its large size and exceptional potency, while. analytical assessment plan. The Company looks forward to feedback. from its planned BPD Type 2b interaction with the FDA in the. second half of 2026, which is expected to help inform the next. phase of development for ABP-450, including clinical pharmacology. -- Strengthened Balance Sheet through a $15.3 Million Financing with","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEON","BBP","BK4022","BK4232","LABU","BK4585","BK4139","BK4588","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907259","title":"Press Release: Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907259","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907259?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565100,"startTime":"0","endTime":"0","summary":"-- On track for September 2026 top-line results from Phase 2b clinical trial.  evaluating laromestrocel as a potential adjunct treatment for. hypoplastic left heart syndrome , a rare pediatric disease and. -- Longeveron selected as a Finalist and Milestone 2 Awardee for the XPRIZE. Healthspan competition based on published clinical trial results which. indicated laromestrocel increased 6-minute walk distance in patients with. -- Three new independent Directors join Longeveron's Board of Directors. laromestrocel as a potential adjunct therapy for HLHS are anticipated in. -- In May, the Company announced that the U.S. Food and Drug Administration.  held a Type C meeting in late March 2026 focused on the ELPIS II. Phase 2b clinical trial and upcoming data readout.-- Also in May, the Company announced that the independent Data Monitoring. Committee  completed its final prespecified data review for ELPIS II. Phase 2b clinical trial . The DMC performed a risk-benefit. assessment, indicated n","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","IND","BK4022","IDNA","EMA","MEDX","R","GDOC","HYLG","LGVN","BK4189","AD","NVIB","DMC","BK4081","BK4139","BK4132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907077","title":"Press Release: MaxCyte Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907077","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907077?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565100,"startTime":"0","endTime":"0","summary":"-- Reports total revenue of $7.3 million for the second quarter of 2026,including $6.5 million of core revenue and $0.8 million of SPL. -- Repurchased approximately $5.5 million of common stock to date under the. Company's $10 million share repurchase program authorized by the Board. -- Following end of quarter, announced strategic, multi-platform technology. of 15% over the second quarter of 2025.-- Core business revenue of $6.5 million in the second quarter of. million for the second quarter of 2026, compared to $0.3 million. -- Gross profit for the second quarter of 2026 was $5.6 million (77% gross. revenue and reserves for excess and obsolete inventory, compared to. non-GAAP adjusted gross margin of 83% in the second quarter of 2025.-- Operating expenses for the second quarter of 2026 were $15.8 million,-- Second quarter 2026 net loss was $8.9 million compared to net loss of","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","MXCT","03160","BK4022","BK4121","TM","BK4604","BK4539","BK4585","BK4555","R","BK4588","BK4099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907036","title":"Press Release: SERA Prognostics Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907036","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907036?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565100,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, Aug. 12, 2026 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company , focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced financial results for the second quarter ended June 30, 2026.Key Second Quarter and Recent Highlights:-- Advanced Commercial Adoption Strategy with Fourth Partnership Program. Launch: In August 2026, we launched fourth partnership program, expanding. implementation of PreTRM Test-guided care through a state-based. initiative with a national payer. We also exceeded our 2026 payer. engagement objective, with active discussions now spanning more than 20. payer opportunities across over 20 states, and are increasingly focused. on advancing implementation, reimbursement readiness, and adoption within. -- Illinois Medicaid Coverage Mandate Expands Access to PreTRM-Test: In June. requiring Medicaid coverage and reimbursement for prescribed proteomic. blood ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4232","BK4139","SERA","BK4539","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659463907","title":"Press Release: Atea Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659463907","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659463907?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565100,"startTime":"0","endTime":"0","summary":"Phase 3 C-BEYOND Trial Met Primary and Secondary Endpoints, with a Short 8-week Duration for Patients Without Cirrhosis Supporting a Potential Best-in-Class Profile of BEM/RZR for Treatment of HCVC-FO","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVIR","BK4007","BK4022","R","CDC","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659385900","title":"Press Release: SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2659385900","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659385900?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565100,"startTime":"0","endTime":"0","summary":"AKI, adding 3 new customers from top-rated children's hospitals, bringing. the total customer base to 20 and building increased depth in customer. orders. This led to second quarter 2026 net revenue of $0.6 million for. QUELIMMUNE product sales, an increase of 82% versus the second quarter of. -- Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial. evaluating the SCD therapy as a potential treatment of adult patients. with AKI in the ICU receiving continuous renal replacement therapy. The. trial has enrolled 223 of 339 patients to date. Completion of enrollment. is anticipated around year end or into the first quarter of 2027, which. would enable a PMA application to the FDA near the end of 2027, pending a. -- Received from the Centers for Medicare & Medicaid Services ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4082","LU2500361329.USD","R","LU1003077747.HKD","LU2637428348.USD","CMS","PMA","LU0738911758.USD","SCD","LU1894683348.USD","LU0661504455.SGD","BK4208","BK4129","BK4585","LU0553294199.USD","LU1894683264.USD","ICU","LU2346227817.USD","BK4022","LU0545039389.USD","LU0949170772.SGD","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659090722","title":"Press Release: QT Imaging Delivers Strong Second Quarter Growth While Building the Foundation for Commercial Scale","url":"https://stock-news.laohu8.com/highlight/detail?id=2659090722","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659090722?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565100,"startTime":"0","endTime":"0","summary":"CT scanners during the second quarter of 2026 and 28 scanners during the. first six months of the year. The revenue for the second quarter of 2026. was $7.4 million. The Company continues to pursue commercial. opportunities through a combination of established distribution partners","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4585","TM","BK4604","BK4555","QTI","BK4099","03160","R","BK4022","BK4082","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659042907","title":"Press Release: BioStem Technologies Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659042907","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659042907?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565100,"startTime":"0","endTime":"0","summary":"Generates 29% sequential revenue growth, increasing to $7.9 million;Raises full-year 2026 revenue guidanceUplists to Nasdaq Capital MarketPOMPANO BEACH, Fla., Aug. 12, 2026  -- BioStem Technologies, Inc. , a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today reported financial results for the second quarter ended June 30, 2026.Recent Corporate Highlights-- Completed the uplisting of the Company's common stock to the Nasdaq. -- Completed a $2.5 million private placement with the Company's first. representing sequential growth of 29% from $6.1 million in the first. -- Continued to scale the commercial organization, expanding the direct. sales force, integrating the CRM and ERP systems, and transitioning all. major group purchasing organization  agreements to broaden access. -- Issued eight new U.S. design patents covering fenestrated human placental","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4585","BK4099","03160","BK4604","BK4555","BSEM","TM","R","BK4588","BK4007","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907649","title":"Press Release: Alto Neuroscience Reports Second Quarter 2026 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907649","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907649?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:03","pubTimestamp":1786564980,"startTime":"0","endTime":"0","summary":"double-blind, placebo-controlled trial conducted by investigators at Lund. University, Sweden -- were published in Nature Medicine. Adults with","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4022","BK4007","BK4232","ANRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659490741","title":"Press Release: Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2659490741","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659490741?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:01","pubTimestamp":1786564860,"startTime":"0","endTime":"0","summary":"increase from $15.0 million for the second quarter of 2025. The increase. was driven by continued commercial demand momentum for Emrosi, which. generated revenues of $8.1 million for the quarter ended June 30, 2026.-- The Company's gross margin was 67% for the second quarter of 2026,-- Selling, general and administrative expenses were $10.9 million for the. second quarter of 2026, a decrease of $1.0 million from the second. quarter of 2025, primarily due to a reduction in launch-related spending. for Emrosi compared to the prior year quarter.-- The Company's GAAP Net Loss narrowed to $0.3 million, or $ per. share basic and diluted, for the second quarter of 2026, compared to a. net loss of $3.8 million, or $ per share basic and diluted, for the. -- The Company's non-GAAP results in the table below reflect positive EBITDA. and Adjusted EBITDA for both the three and six-month periods ended June. -- At June 30, 2026, the Company had $25.6 million in cash and cash. equivalents, as compared","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBIO","BK4139","BK4232","BK4007","R","DERM","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658977936","title":"Press Release: IceCure Reports Its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-over-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2658977936","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658977936?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:30","pubTimestamp":1786537800,"startTime":"0","endTime":"0","summary":"approximately 45% year-over-year revenue growth to $1.8 million during. the first half of 2026, supported by growth in both systems and. disposable probes. Revenue growth was driven by increasing sales of. both ProSense systems and disposable probes, reflecting not only new. customer adoption, but also growing utilization across the Company's. commercial install base.  Gross profit increased to $548,000.-- The Company expanded its U.S. commercial footprint through approximately. 70% growth in its active commercial install base, reflecting increased. physician adoption, higher procedure volumes and continued growth in. -- The Company strengthened its balance sheet during the second quarter of. 2026 with approximately $8.5 million in gross proceeds from. multiple financings and ended the first half of the year with. approximately $12.0 million in cash and cash equivalents.-- IceCure continued to invest in its commercial infrastructure by expanding","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ICCM","BK4232","BK4022","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658972684","title":"Press Release: Masco Corporation Declares Quarterly Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2658972684","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658972684?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:00","pubTimestamp":1786536000,"startTime":"0","endTime":"0","summary":"LIVONIA, Mich.--(BUSINESS WIRE)--August 12, 2026--Masco Corporation (NYSE: MAS) announced that its Board of Directors declared a quarterly dividend of $0.32 per common share, payable on August 28, 202","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1165135440.EUR","LU1543694498.USD","R","BK4585","BK4086","LU0170899867.USD","LU1596574779.USD","BK4232","SG9999001440.SGD","BK4022","LU1620156130.USD","LU2413666004.HKD","BK4588","LU2413665964.HKD","LU1721427968.SGD","MAS","LU1620156213.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658972650","title":"Press Release: Madrigal Appoints John C. Reed, M.D., Ph.D., to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2658972650","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658972650?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:00","pubTimestamp":1786536000,"startTime":"0","endTime":"0","summary":"CONSHOHOCKEN, Pa., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-assoc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","MDGL","BK4232","BK4585","BK4139","BK4588","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658726829","title":"Press Release: Keurig Dr Pepper Announces Appointment of New Director to Its Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2658726829","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658726829?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:00","pubTimestamp":1786536000,"startTime":"0","endTime":"0","summary":"FRISCO, Texas and BURLINGTON, Mass., Aug. 12, 2026 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ: KDP) announced today that Aaron Alt has been appointed a director of the Company's Board of Directors,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","LU0130102774.USD","BK4177","LU0130517989.USD","BK4505","LU1989763427.SGD","BK4535","LU1989763690.USD","LU1201861249.SGD","BK4566","IE00BJTD4N35.SGD","BK4022","BREW","LU0477156953.USD","LU0648001328.SGD","IE00BJTD4V19.USD","KDP","R","LU0980610538.SGD","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658749839","title":"Press Release: Adagene Reports Six Months 2026 Financial Results and Provides Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2658749839","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658749839?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:30","pubTimestamp":1786534200,"startTime":"0","endTime":"0","summary":"patients that have been treated with a muzastotug dose of either 10 mg/kg. -- In the combined 10 mg/kg cohorts, muzastotug achieved an overall","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCC","BK4195","BK4022","BK4232","PFS","BK4139","ORR","BK4006","BK4211","ADAG","COAL","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658971132","title":"Press Release: Kamada Reports Record-High First Half and Second Quarter 2026 Financial Results, Representing Double-Digit Profitable Growth and the Strongest in Kamada's History; Affirms 2026 Annual Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2658971132","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658971132?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:05","pubTimestamp":1786532700,"startTime":"0","endTime":"0","summary":"-- Record-High First Half Revenues of $100.2 Million, up 13% Year-over-Year;Record-High First Half Adjusted EBITDA of $25.7 Million, a 26% margin of. -- Record-High Second Quarter Revenues of $54.9 Million, up 23%. Year-over-Year; Second Quarter Adjusted EBITDA of $14.1 Million, a 26%. -- Net Income for the First Half was $13.4 Million, up 18% Year-over-Year;-- Company Affirms 2026 Annual Guidance of $200 Million -- $205 Million in. Revenues and $50 Million -- $53 Million of Adjusted EBITDA, Representing. -- Strong Cash Generated from Operating Activities of $17.8 Million During. the First Six Months of 2026, Compared to $7.5 Million During the First. -- Secured a First-Time Strategic Three-Year Sales Agreement of. approximately $50 Million to Supply Plasma to a Leading Biopharmaceutical. -- Company Remains Focused on Accelerating Growth Through Business","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","KMDA","BK4232","BK4022","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658971658","title":"Press Release: Kamada Announces Planned Transition of Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2658971658","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658971658?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:00","pubTimestamp":1786532400,"startTime":"0","endTime":"0","summary":"REHOVOT, Israel, and HOBOKEN, N.J., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CFO","BK4022","R","KMDA","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658044979","title":"Press Release: Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2658044979","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658044979?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:00","pubTimestamp":1786532400,"startTime":"0","endTime":"0","summary":"-- Breakthrough results from V012 dialysis access Phase 3 study, where ATEV was observed to outperform AV fistula; supplemental Biologic License Application (sBLA) for dialysis access to be filed with","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAA","SPRE","AV","CTEV","BK4167","IND","BK4232","LABU","BK4215","BK4563","BK4022","BK4588","R","HUMA","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}